Prediction Case File
YouTubeEvaluation Complete

HIMS STOCK IS CRASHING! Here's Why:

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor11 May 2026, 21:48 UTC
Video preview for HIMS STOCK IS CRASHING! Here's Why:
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The stock HIMS experienced a significant drop of 10% in after-hours trading following its earnings report. While subscriber growth was strong at 20%, revenue growth was only 4%, which is considered weak for a growing company. The presenter highlights that international revenue is growing approximately 10x year-over-year, driven by an acquisition in Australia and Japan, contributing to a 25-28% revenue growth forecast for Q2 2026 and 19-28% for FY 2026. Adjusted EBITDA margins are expected to recover from 7% to 11% by FY 2026. However, the recent earnings report and the decline in stock price suggest that the market may be reacting negatively to the company's guidance or performance in key areas, potentially due to increased marketing spend for international expansion and the company's prior divestiture of certain assets. The price-to-sales ratio is noted at 2.72, which is considered low, suggesting the stock might be undervalued given its growth potential and market expansion strategy.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.